As an advocate for the needs of researchers working at the forefronts of genomic research, Integrated DNA Technologies (IDT) releases its latest CRISPR enzyme Alt-R® Cas12a (Cpf1) Ultra. Cas12a Ultra ...

The new tool, which is called CRISPR-Cas12a, can help researchers simultaneously assess the impact of multiple genetic changes involved in variety of immune system responses, the researchers say. “We ...

DETECTR uses a different Cas enzyme, Cas12a, which chops up single-stranded DNA after binding to its target sequence. Initially, the team targeted CRISPR/Cas12a to sequences of human papillomaviruses, ...

1). CRISPR–Cas12a has a low tolerance for base-pair mismatches between the crRNA and the DNA target sequence. Ensoma applied its knowledge of the protein’s structure to further hone ...

Fintel reports that on April 28, 2025, HC Wainwright & Co. initiated coverage of Editas Medicine (NasdaqGS:EDIT) with a Buy ...

The platform utilizes a combined approach involving recombinant polymerase amplification (RPA), the CRISPR/Cas12a system, and an immunochromatographic test strip (ICS). It specifically targets the ...

Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive ...